A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer

被引：39
|
作者：
Anné, PR
Curran, WJ
机构：
[1] Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA USA
[2] Med Oncol Allegheny Gen Hosp, Pittsburgh, PA USA
来源：
SEMINARS IN RADIATION ONCOLOGY | 2002年 / 12卷 / 01期
关键词：
D O I：
10.1053/srao.2002.31358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [1] Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer
    Anné, PR
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 80 - 83
  • [2] A phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer
    Anne, Pramila Rani
    Machtay, Mitchell
    Rosenthal, David I.
    Brizel, David M.
    Morrison, William H.
    Irwin, David H.
    Chougule, Prakash B.
    Estopinal, Noel C.
    Berson, Anthony
    Curran, Walter J., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02): : 445 - 452
  • [3] Phase II trial of subcutaneous Amifostine in patients undergoing radiation therapy for head and neck cancer (vol 29, pg 80, 20020)
    Anne, PR
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 417 - 417
  • [4] Feasibility and efficacy of subcutaneous amifostine in head and neck cancer treated with curative radiation therapy
    Ozsahin, M
    Betz, M
    Matzinger, O
    Azria, D
    Stupp, R
    Luthi, F
    Pasche, P
    Mirimanoff, RO
    Zouhair, A
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 107 - 108
  • [5] A phase II trial of weekly paclitaxel and carboplatin chemotherapy along with radiation and amifostine in patients with locally advanced head and neck cancer
    Hayek, F
    Bhupalam, L
    Paris, KJ
    Flynn, M
    Fleming, D
    Goldsmith, G
    Goldsmith, LJ
    Hendler, F
    Laber, D
    Jose, BO
    Silverman, C
    Bumpous, JM
    Hargis, J
    Khan, Z
    Miller, DM
    Spanos, W
    LUNG CANCER, 2004, 46 : S71 - S72
  • [6] Randomized Phase III trial of radiation (RT)+/-Ethyol(R) (amifostine) in patients with head and neck cancer
    Sauer, R
    Wannenmacher, M
    Brizel, D
    Jones, C
    Henke, M
    Strnad, V
    Eschwege, F
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 234 - 234
  • [7] Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer
    Thorstad, WL
    Chao, KSC
    Haughey, B
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 8 - 12
  • [8] Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy
    Ozsahin, M
    Betz, M
    Matzinger, O
    Bron, L
    Luthi, FO
    Pasche, P
    Azria, D
    Mirimanoff, RO
    Zouhair, A
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (02) : 141 - 145
  • [9] A randomized phase II trial of amifostine for head and neck irradiation in lymphoma
    Ng, AK
    Hickey, G
    Li, SG
    Neuberg, D
    Mauch, PM
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 20 - 24
  • [10] Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: Preliminary data
    Thorstad, WL
    Haughey, B
    Chao, KSC
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 96 - 100
12345